Replies to post #284736 on Avid Bioservices Inc (CDMO)

[stoxx]

They can't cut off supply of money as long as there is ATM and AVID growth will make them cash flow positive in 16-18months.

ATM: Requirements. In order for publicly-traded companies to raise money through an ATM, they must have a shelf registration statement filed with securities regulators, Donaldson said. They must also have a public float of at least $75 million. That’s not feasible for companies of all sizes. “There are a lot of small companies that just can’t do that,” Donaldson said.

http://medcitynews.com/2011/08/at-the-market-offering-for-biotech-funding-review-4-quick-perspectives/


Strategic CFOs in the life science industry are increasingly employing ATMs because they enable companies to better control the financing process and their relatively low cost compared to more traditional follow-on financing vehicles. Despite this growth, some life science issuers might be missing out because of misunderstandings of what ATMs provide and how they work.


http://www.genengnews.com/gen-articles/dispelling-atm-offering-myths/4161


I believe CP has posted about ATM and that it's not being abused.

[eb0783]

This is what has happened to 90% of the small companies, especially the biotechs, that I have ever been invested in. It is cramerism at it's usual.

If they can suffocate the ops then they can cut off pphm's ability to raise money to develop the IP.

Instead of trying to benefit from inventing IP helping humanity and to build EV (economic value) like real investors, they are just as happy to benefit themselves by destroying those companies and raping humanity.